CBDV
Cannabidivarin
Promotes Brain Health & Memory
CBDV (cannabidivarin) promotes a positive mood and sociability, improves brain health and memory, and relieves post-exercise nausea and discomfort. CBDV oil is now being researched for its possible benefits in the treatment of autism spectrum disorder (ASD), attention deficit disorder (ADHD), muscular dystrophy, seizures, and other conditions. (For links to scientific studies, scroll down.)
CBDV Products Coming Soon
CBDV Scientific Studies
CBDV is being studied as a potential treatment for some of the most significant issues related to autism spectrum disorder, including irritability, social functioning and communication, repetitive behaviors, and cognitive problems.
Clinical Trial: Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Q&A with Eric Hollander: Cannabis treatments for autism
CBDV is being studied for potential benefits for attention deficit disorder (ADHD) in this clinical trial: Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD
CBDV is being studied for potential benefits for Prader-Willi Syndrome in this clinical trial: CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
CBDV shows promise in aiding neurobehavioral issues associated with Rett syndrome. In this 2019 preclinical study, CBDV was found to be beneficial for memory, neurological and social deficits related to Rett syndrome.
CBDV was found to reduce inflammation and enhance muscle function in this 2019 study on Duchenne muscular dystrophy (DMD).
CBDV is currently being developed into a pharmaceutical drug designed to reduce or prevent seizures by GW Pharmaceuticals.
CBDV shows potential in reducing nausea in this study.